IL95412A - Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilides - Google Patents

Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilides

Info

Publication number
IL95412A
IL95412A IL9541290A IL9541290A IL95412A IL 95412 A IL95412 A IL 95412A IL 9541290 A IL9541290 A IL 9541290A IL 9541290 A IL9541290 A IL 9541290A IL 95412 A IL95412 A IL 95412A
Authority
IL
Israel
Prior art keywords
carbon atoms
group
compound
bromine
chlorine
Prior art date
Application number
IL9541290A
Other languages
English (en)
Hebrew (he)
Other versions
IL95412A0 (en
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of IL95412A0 publication Critical patent/IL95412A0/xx
Publication of IL95412A publication Critical patent/IL95412A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9541290A 1989-08-18 1990-08-17 Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilides IL95412A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39586089A 1989-08-18 1989-08-18

Publications (2)

Publication Number Publication Date
IL95412A0 IL95412A0 (en) 1991-06-30
IL95412A true IL95412A (en) 1996-01-31

Family

ID=23564835

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9541290A IL95412A (en) 1989-08-18 1990-08-17 Pharmaceutical preparation for the treatment of eye diseases containing 5-methyl-oxazole-4-carboxylic acid anilides and cyanoacetic acid 2-hydroxyethylidine anilides

Country Status (15)

Country Link
EP (1) EP0413329B1 (xx)
JP (1) JP3131693B2 (xx)
KR (1) KR100192745B1 (xx)
AT (1) ATE148628T1 (xx)
AU (1) AU633346B2 (xx)
CA (1) CA2023560C (xx)
DD (1) DD297328A5 (xx)
DE (1) DE69029884T2 (xx)
DK (1) DK0413329T3 (xx)
ES (1) ES2099700T3 (xx)
HU (1) HU215959B (xx)
IE (1) IE902978A1 (xx)
IL (1) IL95412A (xx)
TW (1) TW287948B (xx)
ZA (1) ZA906544B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538783B1 (de) * 1991-10-23 1995-09-27 Hoechst Aktiengesellschaft N-phenyl-2-cyano-3-hydroxycrotonsäureamidderivate und deren Verwendung als Arzneimittel mit immunmodulatorischer Eigenschaft
TW314467B (xx) * 1993-03-31 1997-09-01 Hoechst Ag
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
CA2202904C (en) * 1994-10-17 2006-12-19 Yukio Amano Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
DE102006017896A1 (de) † 2006-04-13 2007-10-25 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Leflunomid enthaltende pharmazeutische Zusammensetzungen
SG11201608835VA (en) 2014-05-08 2016-11-29 Panoptes Pharma Ges M B H Compounds for treating ophthalmic diseases and disorders
WO2023182871A1 (ko) * 2022-03-25 2023-09-28 바스테라 주식회사 3-페닐이속사졸 유도체 및 이를 유효성분으로 함유하는 안질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES448386A1 (es) 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
ES2099700T3 (es) 1997-06-01
HUT59600A (en) 1992-06-29
DE69029884D1 (de) 1997-03-20
JPH0390024A (ja) 1991-04-16
EP0413329A2 (en) 1991-02-20
DD297328A5 (de) 1992-01-09
KR910004193A (ko) 1991-03-28
IL95412A0 (en) 1991-06-30
AU633346B2 (en) 1993-01-28
JP3131693B2 (ja) 2001-02-05
TW287948B (xx) 1996-10-11
DK0413329T3 (da) 1997-08-18
HU905064D0 (en) 1991-01-28
EP0413329B1 (en) 1997-02-05
AU6110490A (en) 1991-02-21
ZA906544B (en) 1991-06-26
DE69029884T2 (de) 1997-08-14
ATE148628T1 (de) 1997-02-15
EP0413329A3 (en) 1992-04-15
IE902978A1 (en) 1991-02-27
CA2023560C (en) 2000-12-12
HU215959B (hu) 1999-03-29
KR100192745B1 (ko) 1999-06-15
CA2023560A1 (en) 1991-02-19

Similar Documents

Publication Publication Date Title
US5677335A (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular disease
EP0413329B1 (en) 5-Methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
US5180721A (en) Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
AU784017B2 (en) Solutions containing epinastine
US5281591A (en) Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5021410A (en) Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
EP0743852A1 (en) Treatment of normotensive glaucoma with angiotensin ii antagonists
WO2008080939A1 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
US6646003B2 (en) Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
US20050009902A1 (en) Remedies for pruritus
US4778814A (en) Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
WO2005067891A1 (en) Compositions comprosing memantine and polyanionic polymers for administration to the eye
WO1993015732A1 (en) Treatment of glaucoma
JPH0525167A (ja) 緑内障の治療に有用な置換ベンゼン誘導体
JP2003201250A (ja) 掻痒治療剤
US5428030A (en) Method of reducing elevated intraocular pressure
JPH0778022B2 (ja) 緑内障治療剤
JPH0797318A (ja) オキシフェドリンを必須成分とする眼圧降下剤
FR2648042A1 (fr) Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
JPH02218612A (ja) 緑内障の治療におけるアンギオテンシン変換酵素阻害剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees